Vandetanib‐associated alopecia areata in a patient with metastatic medullary thyroid cancer

By  

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 54, Iss. 6, 2015-06 ,pp. : e213-e216

John Wiley & Sons Inc

Access to resources Recommend Favorite

Vandetanib in Advanced Medullary Thyroid Cancer: Review of Adverse Event Management Strategies

By Grande Enrique   Kreissl Michael   Filetti Sebastiano   Newbold Kate   Reinisch Walter   Robert Caroline   Schlumberger Martin   Tolstrup Lærke   Zamorano Jose   Capdevila Jaume  

Advances in Therapy, Vol. 30, Iss. 11, 2013-11 ,pp. : 945-966

Springer Publishing Company

Access to resources Recommend Favorite

Metastatic medullary thyroid carcinoma to the breast in a patient with combined medullary and papillary carcinoma of thyroid—A case report

By  

DIAGNOSTIC CYTOPATHOLOGY, Vol. 43, Iss. 4, 2015-04 ,pp. : 343-348

John Wiley & Sons Inc

Access to resources Recommend Favorite

Surgical Approach to the Management of Medullary Thyroid Cancer: When Is Lymph Node Dissection Needed?

By  

Oncology, Vol. 84, Iss. 6, 2013-05 ,pp. : 350-355

Karger

Access to resources Recommend Favorite

Twenty years of lesson learning: how does the RET genetic screening test impact the clinical management of medullary thyroid cancer?

By  

CLINICAL ENDOCRINOLOGY, Vol. 82, Iss. 6, 2015-06 ,pp. : 892-899

John Wiley & Sons Inc

Access to resources Recommend Favorite